Use of beta-agonist therapy prior to hospital attendance for severe exacerbations of asthma

M. Patel, J. Pilcher, R. Hancox, D. Sheahan, D. Shaw, M. Weatherall, R. Beasley (Wellington, Hamilton, Dunedin, Tauranga, New Zealand; Nottingham, United Kingdom)

Source: Annual Congress 2013 –Predictors and triggers of asthma and COPD exacerbations
Session: Predictors and triggers of asthma and COPD exacerbations
Session type: Thematic Poster Session
Number: 775
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. Patel, J. Pilcher, R. Hancox, D. Sheahan, D. Shaw, M. Weatherall, R. Beasley (Wellington, Hamilton, Dunedin, Tauranga, New Zealand; Nottingham, United Kingdom). Use of beta-agonist therapy prior to hospital attendance for severe exacerbations of asthma. Eur Respir J 2013; 42: Suppl. 57, 775

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Predictors of severe asthma exacerbations, poor asthma control and beta-agonist overuse in adult asthma
Source: Annual Congress 2013 –Predictors and triggers of asthma and COPD exacerbations
Year: 2013


Acute exacerbations of asthma in Barcelona, the recent experience
Source: Annual Congress 2013 –Epidemiology of asthma
Year: 2013


Use of β-blockers and the risk of asthma exacerbations
Source: International Congress 2016 – Asthma: from basic mechanisms to novel therapeutic perspectives
Year: 2016


Respiratory effectiveness group study: Predictors of frequent severe asthma exacerbations
Source: International Congress 2015 – Management of asthma and COPD in primary care
Year: 2015


Asthma control, symptoms and exacerbations across treatment levels in patients with asthma
Source: Annual Congress 2013 –Management of respiratory diseases in primary care
Year: 2013


Predictors of 90 day readmission in hospitalized patients for asthma exacerbation
Source: International Congress 2015 – Clinical assessment and monitoring of asthma and COPD
Year: 2015


Factors related with hospitalizations due to asthma exacerbations
Source: International Congress 2015 – Non-inflammatory monitoring of airway diseases
Year: 2015


Characteristics and medication use of the patients with acute exacerbations of asthma-COPD overlap syndrome
Source: International Congress 2015 – Is asthma always an easy disease to diagnose and manage?
Year: 2015


Finding asthmatics suitable for omalizumab therapy in a district hospital
Source: Annual Congress 2013 –Phenotyping asthma: clinical severity, comorbid conditions response to treatment?
Year: 2013


Evaluation of methotrexate in the treatment of severe asthma
Source: International Congress 2015 – Novel treatments for cough, asthma, COPD and bronchiectasis
Year: 2015


Use of long acting bronchodilators and inhaled corticosteroids within 30-days of discharge in older adults hospitalized for AECOPD
Source: International Congress 2015 – Treatment and control of respiratory disease
Year: 2015


Predictors of exacerbations in asthma
Source: International Congress 2015 – Clinical assessment in asthma and COPD
Year: 2015


Erdosteine oral treatment of hospitalised COPD exacerbation prolongs time to first re-exacerbation
Source: International Congress 2014 – Clinical trials of drugs and biomarkers for respiratory diseases
Year: 2014


Adherence and effectiveness of omalizumab treatment in severe allergic asthma patients: Do the patients like injectable treatment?
Source: Annual Congress 2013 –Treatment of asthma
Year: 2013


A comparison of general and respiratory physicans’ follow up arrangements post discharge after asthma exacerbations
Source: International Congress 2016 – Monitoring airway diseases with clinical tools
Year: 2016

Effectiveness of self-treatment of exacerbations in COPD patients: Two-year follow-up of the COPE-II study
Source: International Congress 2014 – Best abstracts in rehabilitation and chronic care (sponsored by MOTEK Medical)
Year: 2014

Frequency of COPD exacerbations in the real-life out-patient DACCORD cohort
Source: International Congress 2014 – Rationale behind respiratory drug development
Year: 2014

Dupilumab reduces severe exacerbations in periostin-high and periostin-low asthma patients
Source: International Congress 2016 – Asthma: from basic mechanisms to novel therapeutic perspectives
Year: 2016



Excess inhaled corticosteroid adherence may be a marker of uncontrolled asthma
Source: Annual Congress 2013 –Quality of diagnosis and assessment in primary care
Year: 2013


Is therapy adherence to inhaled corticosteroids related to hospitalization, pneumonia or mortality in COPD?
Source: International Congress 2014 – New clinical evidence for asthma and COPD treatments
Year: 2014